M. Yu. Belikov et al. / Tetrahedron Letters 52 (2011) 6407–6410
CN CN
6409
CN
NC
NC
NC
NH
NH
R2
R2
R1
R2
R1
CN
CN
NH
CN
O
O
1
CN
NH2
O
+
NH2
R1
O
O
N
O
O
А
B
C
NC
O
NC
NH2
NH2
+
NC
NC
NH2
R2
R1
R2
R1
O
N
N
2
NH
N
N
O
O
O
O
E
D
Scheme 2. A possible mechanism for the formation of 3H-pyrroles 2.
NC
CN
CN
NH2
NC
NC
NC
CN
NH
R2
R1
CN
NH
O
N
Ph
NH
- PhC(O)H
O
O
N
O
O
4
2e
B
O
Scheme 3. Cross-synthesis of 3H-pyrrole 2e.
49–52; (c) Padmavathi, V.; Radha, L. T.; Mahesh, K.; Padmaja, A. A. Chem. Pharm.
Bull. 2009, 57, 1200–1205.
Acknowledgment
5. Typical procedure for the preparation of 5-amino-2-morpholin-4-yl-3-(2-aryl-2-
oxo)-3H-pyrrole-3,4-dicarbonitriles 2a–d. To a stirred solution of the appropriate
4-aryl-4-oxobutane-1,1,2,2-tetracarbonitrile 1a–d (0.5 mmol) in dry EtOAc
(3 ml) at À5 to À10 °C was added morpholine (1 mmol) and the reaction
mixture became yellow-orange in color. After 2–3 d at À5 to À10 °C the
precipitated light-yellow solid was filtered, washed sequentially with cold
EtOAc (2 ml) and Et2O (1 ml) and dried. Typical procedure for the preparation of 5-
amino-2-morpholin-4-yl-3-(2-oxocyclohexyl)-3H-pyrrole-3,4-dicarbonitriles 2e,f.
To a stirred suspension of the appropriate 1-(2-oxocyclohexyl)ethane-1,1,2,2-
tetracarbonitrile 1e,f (0.5 mmol) in a 10:1 mixture of H2O and iPrOH (5 ml) was
added morpholine (1 mmol) and the reaction mixture became transparent yellow
in color. After stirring at room temperature for 15–30 min the newly precipitated
solid was filtered, washed sequentially with H2O (5 ml) and iPrOH (2 ml). The
isolated products were purified by crystallization from iPrOH and dried.
6. Analytical data for compounds 2a–f. Compound 2a. mp 208–209 °C; 1H NMR
This research was supported by the Federal Target Program
(Reseach and educational personnel of innovative Russia) as
research project (No 16.740.11.0160).
References and notes
1. (a) Middleton, W. J.; Heckert, R. E.; Little, E. L.; Krespas, C. G. J. Am. Chem. Soc.
1958, 80, 2783–2788; (b) Nikolaev, E. G.; Nasakin, O. E.; Terent’ev, P. B.; Khaskin,
B. A.; Petrov, V. G. Zh. Org. Khim. 1984, 20, 205–206.
2. (a) Nasakin, O. E.; Sheverdov, V. P.; Ershov, O. V.; Moiseeva, I. V.; Lyshchikov, A.
N.; Khrustalev, V. N.; Yu Antipin, M. Mendeleev Commun. 1997, 7, 112–113; (b)
Nasakin, O. E.; Sheverdov, V. P.; Moiseeva, I. V.; Lyshchikov, A. N.; Ershov, O. V.;
Nesterov, V. N. Tetrahedron Lett. 1997, 38, 4455–4456; (c) Yu Belikov, M.; Ershov,
O. V.; Eremkin, A. V.; Kayukov, Ya. S.; Nasakin, O. E. Zh. Org. Khim. 2010, 46, 604–
605 (Russ. J. Org. Chem. 2010, 46, 597–598); (d) Yu Belikov, M.; Ershov, O. V.;
Eremkin, A. V.; Kayukov, Ya. S.; Nasakin, O. E. Zh. Org. Khim. 2010, 46, 621–622
(Russ. J. Org. Chem. 2010, 46, 615–616); (e) Takehana, T.; Shimizu, K.; Yokozawa,
T.; Kimura, T.; Nishikata, A. Tetrahedron Lett. 1999, 40, 4707–4710; (f) Nasakin,
O. E.; Sheverdov, V. P.; Moiseeva, I. V.; Lyshchikov, A. N.; Ershov, O. V.;
Chernushkin, A. N.; Nesterov, V. N. Zh. Obsch. Khim. 1999, 69, 302–311; (g)
Ducker, J. M.; Gunter, M. J. Aust. J. Chem. 1973, 26, 1551–1569; (h) Nasakin, O. E.;
Lyshchikov, A. N.; Kayukov, Ya S.; Sheverdov, V. P. Pharm. Chem. J. 2000, 34, 170–
185.
3. (a) Ichikawa, J.; Sakoda, K.; Mihara, J.; Ito, N. J. Fluorine Chem. 2006, 127, 489–
504; (b) Svilarich-Soenen, M.; Foucaud, A. Tetrahedron 1972, 28, 5149–5155; (c)
Korostova, S. E.; Schevchenko, S. G.; Sigalov, M. V. Chem. Heterocycl. Compd.
1991, 27, 1101–1104; (d) Depature, M.; Grimaldi, Ja.; Hatem, Ja. Eur. J. Org. Chem
2001, 941–946; (e) Soufyane, M.; Mirand, C.; Lévy, J. Tetrahedron Lett. 1993, 34,
7737–7740; (f) Lui, K. H.; Sammes, M. P. J. Chem. Soc., Perkin Trans. 1 1990, 457–
468; (g) Chiu, P. K.; Lai, T. P.; Sammes, M. P. J. Chem. Res. (M). 1990, 428–439; (h)
Merot, P.; Gadreau, C.; Foucaud, A. Tetrahedron 1981, 37, 2595–2599; (i)
Foucaud, A.; Leblanc, R. Tetrahedron Lett. 1969, 10, 509–512; (j) Firestone, R. A.
Tetrahedron 1977, 33, 3009–3039; (k) McEwen, W. E.; Yee, T. T.; Liao, T. K.; Wolf,
A. P. J. Org. Chem. 1967, 32, 1947–1954; (l) Jacobi, P. A.; Liu, H. J. Am. Chem. Soc.
1999, 121, 1958–1959; (m) Chiu, P.-H.; Sammes, M. P. Tetrahedron 1990, 46,
3439–3456; (n) Schmitt, G.; Nasser, B.; Dinh, N.; Laude, B.; Roche, M. Can. J.
Chem. 1990, 68, 863–868; (o) Xu, X.; Zhang, Y. Synth. Commun. 2002, 32, 2643–
2650; (p) Xu, X.; Zhang, Y. J. Chem. Soc., Perkin Trans. 1 2001, 2836–2839.
4. (a) Cirrincione, G.; Almerico, A. M.; Dattolo, G.; Aiello, E.; Grimaudo, S.; Diana, P.;
Misuraca, F. Farmaco 1992, 47, 1555–1562; (b) Cirrincione, G.; Almerico, A. M.;
Grimaudo, S.; Diana, P.; Mingoia, F.; Barraja, P.; Misuraca, F. Farmaco 1996, 51,
(500.13 MHz, DMSO-d6):
d 3.62–3.80 (8H, m, morpholine), 3.92 (1H, d,
J = 17.8 Hz, CH2CO), 4.06 (1H, d, J = 17.8 Hz, CH2CO), 7.27 (2H, s, NH2), 7.53–
7.57 (2H, m, 2-m-H-Ar), 7.67–7.70 (1H, m, 1-p-H-Ar), 7.98–8.01 (2H, m, 2-o-H-
Ar). 13C NMR (125.76 MHz, DMSO-d6): d 42.73, 47.45, 57.54, 65.98, 117.56,
118.54, 128.66, 129.17, 134.24, 136.17, 170.66, 170.94, 194.10. IR (mineral oil,
cmÀ1) 3184–3311 (NH2), 2232, 2182 (C„N), 1691 (C@O). MS (EI, 70 eV): m/z (%)
335 (M+, 72), 216 (100). Anal. Calcd for C18H17N5O2: C, 64.47; H, 5.11; N, 20.88.
Found: C, 64.57; H, 5.02; N, 20.97. Compound 2b. mp 220–221 °C; 1H NMR
(500.13 MHz, DMSO-d6):
d 3.66–3.78 (8H, m, morpholine), 3.90 (1H, d,
J = 17.7 Hz, CH2CO), 4.06 (1H, d, J = 17.7 Hz, CH2CO), 7.26 (2H, s, NH2), 7.61–
7.64 (2H, m, H3,5-Ar), 7.99–8.03 (2H, m, H2,6-Ar). IR (mineral oil, cmÀ1) 3157–
3403 (NH2), 2233, 2172 (C„N), 1667 (C@O). MS (EI, 70 eV): m/z (%) 369 (M+, 3),
216 (100). Anal. Calcd for C18H16ClN5O2: C, 58.46; H, 4.36; N, 18.94. Found: C,
58.53; H, 4.31; N, 19.02. Compound 2c. mp 229–230 °C; 1H NMR (500.13 MHz,
DMSO-d6): d 3.67–3.79 (8H, m, morpholine), 3.96 (1H, d, J = 17.7 Hz, CH2CO),
4.10 (1H, d, J = 17.7 Hz, CH2CO), 7.29 (2H, s, NH2), 7.43–7.46 (1H, m, Ar), 7.50–
7.54 (2H, m, Ar), 7.74–7.79 (2H, m, Ar), 7.82–7.87 (2H, m, Ar), 8.04–8.10 (2H, m,
Ar). IR (mineral oil, cmÀ1) 3167–3401 (NH2), 2234, 2179 (C„N), 1668 (C@O). MS
(EI, 70 eV): m/z (%) 411 (M+, 3), 216 (100). Anal. Calcd for C24H21N5O2: C, 70.06;
H, 5.14; N, 17.02. Found: C, 69.89; H, 5.18; N, 17.13. Compound 2d. mp 211–
212 °C; 1H NMR (500.13 MHz, DMSO-d6): d 0.98 (3H, d, J = 6.9 Hz, CH3), 3.68–
3.76 (8H, m, morpholine), 3.86 (3H, s, OCH3), 4.26 (1H, q, J = 6.9 Hz, CHCH3), 7.08
(2H, d, J = 8.9 Hz, H3,5-Ar), 7.28 (2H, s, NH2), 8.00 (2H, d, J = 8.9 Hz, H2,6-Ar). IR
(mineral oil, cmÀ1) 3149–3347 (NH2), 2233, 2169 (C„N), 1672 (C@O). MS (EI,
70 eV): m/z (%) 379 (M+, 5), 216 (100). Anal. Calcd for C20H21N5O3: C, 63.31; H,
5.58; N, 18.46. Found: C, 63.33; H, 5.51; N, 18.52. Compound 2e. mp 195–196 °C;
1H NMR (500.13 MHz, DMSO-d6): d 1.24–2.42 (8H, m, 4CH2), 3.43 (1H, dd,
J = 5.5, 12.6 Hz CHCO); 3.50–3.85 (8H, m, morpholine), 7.19⁄, 7.27 (2H, s, NH2).
1H NMR (500.13 MHz, DMSO-d6, 348 K): d 1.28–2.38 (8H, m, 4CH2), 3.37 (1H, dd,